Prevalence of shigellosis in the US: Consistency with dose-response information

被引:67
作者
Crockett, CS
Haas, CN
Fazil, A
Rose, JB
Gerba, CP
机构
[1] DREXEL UNIV,INST ENVIRONM STUDIES,PHILADELPHIA,PA 19104
[2] PHILADELPHIA WATER DEPT,PHILADELPHIA,PA 19124
[3] UNIV S FLORIDA,DEPT MARINE SCI,ST PETERSBURG,FL 33701
[4] UNIV ARIZONA,DEPT SOIL & WATER SCI,TUCSON,AZ
关键词
Shigella; dose-response; infectious dose; shigellosis; risk assessment;
D O I
10.1016/0168-1605(96)00993-2
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Every year there are estimated 300 000 cases of Shigella in the United States-(Bennett et al., 1987, Am. J. Prev. Med. 3, 102-114). A beta-poisson model was fit to human dose-response information on pathogenic Shigella using the Maximum Likelihood Estimation technique (Haast 1983, Am. J. Epidemiol. 118, 573-582). Pooled and separate data sets for the Shigella species were fit to the beta-Poisson model and 95% confidence limits and regions were calculated. Shigella dysentariae and Shigella flexneri confidence regions and limits overlapped with each other and with the pooled data set, suggesting that this model can describe Shigella in general. The pooled Shigella model as well as the upper and lower confidence limits of the three data sets showed average exposures based on the estimated U.S. caseload of pathogenic Shigella of 0.01 to 0.014 organisms (confidence limits 0.001-0.05) for a 7-day per annum period of exposure and ranges from 0.07 to 0.1 organisms (confidence limits 0.006-0.4). for a 1-day per annum period of exposure. The plausibility of the pooled dose-response model was then evaluated by comparison with two known cruise ship outbreaks. The pooled model estimated that the two outbreaks studied could have been due to ingestion of 344 (confidence limits 72-915) Shigella cells per meal and 10.5-12 (confidence limits 1-44) Shigella cells per glass of water by passengers.
引用
收藏
页码:87 / 99
页数:13
相关论文
共 22 条
[1]  
Bennett J. V., 1987, AM J PREV MED
[2]  
BLACK RE, 1978, AM J EPIDEMIOL, V108, P47
[3]  
BLOSTEIN J, 1991, PUBLIC HEALTH REP, V106, P317
[4]  
*CDC PREV, 1994, 9420 EPI AID CDC PRE
[5]   IMMUNITY IN SHIGELLOSIS .2. PROTECTION INDUCED BY ORAL LIVE VACCINE OR PRIMARY INFECTION [J].
DUPONT, HL ;
GANGAROSA, EJ ;
LIBONATI, JP ;
HORNICK, RB ;
SNYDER, MJ ;
FORMAL, SB .
JOURNAL OF INFECTIOUS DISEASES, 1972, 125 (01) :12-+
[6]   RESPONSE OF MAN TO VIRULENT SHIGELLA FLEXNERI 2A [J].
DUPONT, HL ;
HORNICK, RB ;
DAWKINS, AT ;
SNYDER, MJ ;
FORMAL, SB .
JOURNAL OF INFECTIOUS DISEASES, 1969, 119 (03) :296-&
[7]  
DUPONT HL, 1973, MEDICINE, V52, P265
[8]   WATERBORNE TRANSMISSION AND THE EVOLUTION OF VIRULENCE AMONG GASTROINTESTINAL BACTERIA [J].
EWALD, PW .
EPIDEMIOLOGY AND INFECTION, 1991, 106 (01) :83-119
[9]   A MATHEMATICAL MODEL FOR INFECTIVITY-DILUTION CURVE OF TOBACCO MOSAIC VIRUS - EXPERIMENTAL TESTS [J].
FURUMOTO, WA ;
MICKEY, R .
VIROLOGY, 1967, 32 (02) :224-&
[10]   A MATHEMATICAL MODEL FOR INFECTIVITY-DILUTION CURVE OF TOBACCO MOSAIC VIRUS - THEORETICAL CONSIDERATIONS [J].
FURUMOTO, WA ;
MICKEY, R .
VIROLOGY, 1967, 32 (02) :216-&